|
1
|
Cho H, Kim YT and Kim JH: Accuracy of
preoperative tests in clinical stage I endometrial cancer: the
importance of lymphadenectomy. Acta Obstet Gynecol Scand.
89:175–181. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nguyen ML, Lafargue CJ, Pua TL and
Tedjarati SS: Grade 1 endometrioid endometrial carcinoma presenting
with pelvic bone metastasis: a case report and review of the
literature. Case Rep Obstet Gynecol. 2013:8072052013.PubMed/NCBI
|
|
3
|
Banno K, Nogami Y, Kisu I, Yanokura M,
Umene K, Masuda K, Kobayashi Y, Yamagami W, Susumu N and Aoki D:
Candidate biomarkers for genetic and clinicopathological diagnosis
of endometrial cancer. Int J Mol Sci. 14:12123–12137. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
5
|
Jiang F, Liu T, He Y, Yan Q, Chen X, Wang
H and Wan X: MiR-125b promotes proliferation and migration of type
II endometrial carcinoma cells through targeting TP53INP1 tumor
suppressor in vitro and in vivo. BMC Cancer. 11:4252011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wild PJ, Ikenberg K, Fuchs TJ, Rechsteiner
M, Georgiev S, Fankhauser N, Noske A, Roessle M, Caduff R, Dellas
A, Fink D, Moch H, Krek W and Frew IJ: p53 suppresses type II
endometrial carcinomas in mice and governs endometrial tumour
aggressiveness in humans. EMBO Mol Med. 4:808–824. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gehrig PA and Bae-Jump VL: Promising novel
therapies for the treatment of endometrial cancer. Gynecol Oncol.
116:187–194. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen F and Hu SJ: Effect of microRNA-34a
in cell cycle, differentiation, and apoptosis: a review. J Biochem
Mol Toxicol. 26:79–86. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iorio MV and Croce CM: MicroRNAs in
cancer: small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA and Croce CM: Chromosomal
rearrangements and microRNAs: a new cancer link with clinical
implications. J Clin Invest. 117:2059–2066. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He L, He X, Lim LP, de Stanchina E, Xuan
Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL,
Linsley PS, Chen C, Lowe SW, Cleary MA and Hannon GJ: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Olive V, Jiang I and He L: mir-17-92, a
cluster of miRNAs in the midst of the cancer network. Int J Biochem
Cell Biol. 42:1348–1354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang X, Feng M, Jiang X, Wu Z, Li Z, Aau M
and Yu Q: miR-449a and miR-449b are direct transcriptional targets
of E2F1 and negatively regulate pRb-E2F1 activity through a
feedback loop by targeting CDK6 and CDC25A. Genes Dev.
23:2388–2393. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Noonan EJ, Place RF, Pookot D, Basak S,
Whitson JM, Hirata H, Giardina C and Dahiya R: miR-449a targets
HDAC-1 and induces growth arrest in prostate cancer. Oncogene.
28:1714–1724. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen H, Lin YW, Mao YQ, Wu J, Liu YF,
Zheng XY and Xie LP: MicroRNA-449a acts as a tumor suppressor in
human bladder cancer through the regulation of pocket proteins.
Cancer Lett. 320:40–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Buurman R, Gürlevik E, Schäffer V, Eilers
M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F and
Skawran B: Histone deacetylases activate hepatocyte growth factor
signaling by repressing microRNA-449 in hepatocellular carcinoma
cells. Gastroenterology. 143:811–820. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bou Kheir T, Futoma-Kazmierczak E,
Jacobsen A, Krogh A, Bardram L, Hother C, Grønbæk K, Federspiel B,
Lund AH and Friis-Hansen L: miR-449 inhibits cell proliferation and
is down-regulated in gastric cancer. Mol Cancer.
10:292011.PubMed/NCBI
|
|
18
|
Ren XS, Yin MH, Zhang X, Wang Z, Feng SP,
Wang GX, Luo YJ, Liang PZ, Yang XQ, He JX and Zhang BL:
Tumor-suppressive microRNA-449a induces growth arrest and
senescence by targeting E2F3 in human lung cancer cells. Cancer
Lett. 344:195–203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Umene K, Banno K, Kisu I, Yanokura M,
Nogami Y, Tsuji K, Masuda K, Ueki A, Kobayashi Y, Yamagami W,
Tominaga E, Susumu N and Aoki D: New candidate therapeutic agents
for endometrial cancer: Potential for clinical practice (Review).
Oncol Rep. 29:855–860. 2013.PubMed/NCBI
|
|
20
|
Boren T, Xiong Y, Hakam A, Wenham R, Apte
S, Wei Z, Kamath S, Chen DT, Dressman H and Lancaster JM: MicroRNAs
and their target messenger RNAs associated with endometrial
carcinogenesis. Gynecol Oncol. 110:206–215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsuruta T, Kozaki K, Uesugi A, Furuta M,
Hirasawa A, Imoto I, Susumu N, Aoki D and Inazawa J: miR-152 is a
tumor suppressor microRNA that is silenced by DNA hypermethylation
in endometrial cancer. Cancer Res. 71:6450–6462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hiroki E, Suzuki F, Akahira J, Nagase S,
Ito K, Sugawara J, Miki Y, Suzuki T, Sasano H and Yaegashi N:
MicroRNA-34b functions as a potential tumor suppressor in
endometrial serous adenocarcinoma. Int J Cancer. 131:E395–E404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meng F, Henson R, Lang M, Wehbe H,
Maheshwari S, Mendell JT, Jiang J, Schmittgen TD and Patel T:
Involvement of human micro-RNA in growth and response to
chemotherapy in human cholangiocarcinoma cell lines.
Gastroenterology. 130:2113–2129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu T, Yu X, Li G, Yuan R, Wang Q, Tang P,
Wu L, Liu X, Peng X and Shao J: Rock2 regulates Cdc25A through
ubiquitin proteasome system in hepatocellular carcinoma cells. Exp
Cell Res. 318:1994–2003. 2012. View Article : Google Scholar : PubMed/NCBI
|
